icon-folder.gif   Conference Reports for NATAP  
 
  EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands
 Back grey_arrow_rt.gif
 
 
 
Elafibranor impacts inflammatory, fibrotic and symptom-associated markers in patients with primary biliary cholangitis: Proteomic results from the ELATIVE® trial
 
 
  EASL 2025 May 7-10 Amsterdam

0512251

0512252

0512253

0512254

0512255

0512256

0512257

0512258

0512259